These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH; Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995 [TBL] [Abstract][Full Text] [Related]
5. Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy. Ingram PR; Lye DC; Tambyah PA; Goh WP; Tam VH; Fisher DA J Antimicrob Chemother; 2008 Jul; 62(1):168-71. PubMed ID: 18334494 [TBL] [Abstract][Full Text] [Related]
6. Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients. Cohen E; Dadashev A; Drucker M; Samra Z; Rubinstein E; Garty M J Antimicrob Chemother; 2002 Jan; 49(1):155-60. PubMed ID: 11751780 [TBL] [Abstract][Full Text] [Related]
7. Mississippi mud no more: cost-effectiveness of pharmacokinetic dosage adjustment of vancomycin to prevent nephrotoxicity. Darko W; Medicis JJ; Smith A; Guharoy R; Lehmann DE Pharmacotherapy; 2003 May; 23(5):643-50. PubMed ID: 12741439 [TBL] [Abstract][Full Text] [Related]
8. A prospective study of adverse reactions associated with vancomycin therapy. Sorrell TC; Collignon PJ J Antimicrob Chemother; 1985 Aug; 16(2):235-41. PubMed ID: 3934126 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Burgess LD; Drew RH Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041 [TBL] [Abstract][Full Text] [Related]
10. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy. Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556 [TBL] [Abstract][Full Text] [Related]
11. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity. Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869 [TBL] [Abstract][Full Text] [Related]
12. Vancomycin ototoxicity and nephrotoxicity. A review. Bailie GR; Neal D Med Toxicol Adverse Drug Exp; 1988; 3(5):376-86. PubMed ID: 3057327 [TBL] [Abstract][Full Text] [Related]